Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can we predict which preemies will need a breathing tube?

NCT ID NCT05260424

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 397 premature babies (under 32 weeks) who were given non-invasive breathing support. Researchers looked for early clues, like how much extra oxygen the babies needed, to predict which ones would later need a breathing tube. The goal is to help doctors decide earlier when to give surfactant medicine to prevent breathing failure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which premature babies need a breathing tube sooner, potentially reducing complications.
What could go wrong
This is an observational study, not a treatment trial. It identifies risk factors but does not test a new therapy, so direct patient benefit is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

397 people

The number who actually took part.

Started

Dec 2020

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Preterm babies \< 32 weeks gestational age who have received nasal intermittent positive pressure ventilation.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \<32 weeks preterm babies * Those who have received nasal intermittent positive pressure ventilation Exclusion Criteria: * Babies born\> 32 weeks * Babies with congenital anomalies * Babies who have intubated in the delivery room * Babies whose parents refuse to participitate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Premature are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

newborn respiratory distress syndrome Premature Birth Respiratory Distress Syndrome, Newborn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara City Hospital Bilkent

    Ankara, 06000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.